Myelin ingestion by macrophages promotes their motility and capacity to recruit myeloid cells

Journal of Neuroimmunology

Volumn 225, Issue 1-2, 2010, Pages 112-117

  van Zwam, Marloes ^a   Wierenga Wolf, Annet F ^a   Melief, Marie José ^a   Schrijver, Benjamin ^a   Laman, Jon D ^a   Boven, Leonie A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cerebrospinal fluid; Cervical lymph nodes; Immune cell trafficking; Macrophages; Multiple sclerosis

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MYELIN; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; LYMPH NODE; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL MOVEMENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MACROPHAGES; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MYELIN SHEATH; MYELOID CELLS; RECEPTORS, CCR7; RECEPTORS, CXCR3; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 77955658830     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.04.021     Document Type: Article

References (49)

1. Balashov K.E., Rottman J.B., Weiner H.L., Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U S A 1999, 96:6873-6878.
2. Benveniste E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 1997, 75:165-173.
3. Biber K., Sauter A., Brouwer N., Copray S.C., Boddeke H.W. Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). Glia 2001, 34:121-133.
4. Boven L.A., Montagne L., Nottet H.S., De Groot C.J. Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions. Clin. Exp. Immunol. 2000, 122:257-263.
5. Boven L.A., Van Meurs M., Van Zwam M., Wierenga-Wolf A., Hintzen R.Q., Boot R.G., Aerts J.M., Amor S., Nieuwenhuis E.E., Laman J.D. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 2006, 129:517-526.
6. de Jong E.K., Dijkstra I.M., Hensens M., Brouwer N., van Amerongen M., Liem R.S., Boddeke H.W., Biber K. Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J. Neurosci. 2005, 25:7548-7557.
7. de Vos A.F., van Meurs M., Brok H.P., Boven L.A., Hintzen R.Q., van der Valk P., Ravid R., Rensing S., Boon L., 't Hart B.A., Laman J.D. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J. Immunol. 2002, 169:5415-5423.
8. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998, 188:373-386.
9. Fabriek B.O., Zwemmer J.N., Teunissen C.E., Dijkstra C.D., Polman C.H., Laman J.D., Castelijns J.A. In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology. J. Neuroimmunol. 2005, 161:190-194.
10. Glabinski A.R., Tani M., Tuohy V.K., Tuthill R.J., Ransohoff R.M. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav. Immun. 1995, 9:315-330.
11. Herndon R.M., Kasckow J. Electron microscopic studies of cerebrospinal fluid sediment in demyelinating disease. Ann. Neurol. 1978, 4:515-523.
12. Kivisakk P., Mahad D.J., Callahan M.K., Sikora K., Trebst C., Tucky B., Wujek J., Ravid R., Staugaitis S.M., Lassmann H., Ransohoff R.M. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 2004, 55:627-638.
13. Klein R.S., Lin E., Zhang B., Luster A.D., Tollett J., Samuel M.A., Engle M., Diamond M.S. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 2005, 79:11457-11466.
14. Kobayashi H., Miura S., Nagata H., Tsuzuki Y., Hokari R., Ogino T., Watanabe C., Azuma T., Ishii H. In situ demonstration of dendritic cell migration from rat intestine to mesenteric lymph nodes: relationships to maturation and role of chemokines. J. Leukoc. Biol. 2004, 75:434-442.
15. Krumbholz M., Theil D., Steinmeyer F., Cepok S., Hemmer B., Hofbauer M., Farina C., Derfuss T., Junker A., Arzberger T., Sinicina I., Hartle C., Newcombe J., Hohlfeld R., Meinl E. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. J. Neuroimmunol. 2007, 190:72-79.
16. Li H., Cuzner M.L., Newcombe J. Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 1996, 22:207-215.
17. Liu L., Callahan M.K., Huang D., Ransohoff R.M. Chemokine receptor CXCR3: an unexpected enigma. Curr. Top. Dev. Biol. 2005, 68:149-181.
18. Liu L., Huang D., Matsui M., He T.T., Hu T., Demartino J., Lu B., Gerard C., Ransohoff R.M. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis. J. Immunol. 2006, 176:4399-4409.
19. Liu Y., Hao W., Letiembre M., Walter S., Kulanga M., Neumann H., Fassbender K. Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J. Neurosci. 2006, 26:12904-12913.
20. Matsumo Y., Sakuma H., Miyakoshi A., Tsukada Y., Kohyama K., Park I.K., Tanuma N. Characterization of relapsing autoimmune encephalomyelitis and its treatment with decoy chemokine receptor genes. J. Neuroimmunol. 2005, 170:49-61.
21. Moreira M.A., Souza A.L., Lana-Peixoto M.A., Teixeira M.M., Teixeira A.L. Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis. Braz. J. Med. Biol. Res. 2006, 39:441-445.
22. Morell P., Quarles R.H. Myelin formation, structure and biochemistry. Basic Neurochemistry; Molecular, Cellular and Medical Aspects 1999, Lippincot Williams Wilkens. G.J. Siegel, B.W. Agranoff, R.W. Albers, S.K. Fisher, M.D. Uhler (Eds.).
23. Muller G., Lipp M. Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr. Opin. Immunol. 2003, 15:217-224.
24. Muller M., Carter S.L., Hofer M.J., Manders P., Getts D.R., Getts M.T., Dreykluft A., Lu B., Gerard C., King N.J., Campbell I.L. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J. Immunol. 2007, 179:2774-2786.
25. Norton W.T., Poduslo S.E. Myelination in rat brain: method of myelin isolation. J. Neurochem. 1973, 21:749-757.
26. Omari K.M., Chui R., Dorovini-Zis K. Induction of beta-chemokine secretion by human brain microvessel endothelial cells via CD40/CD40L interactions. J. Neuroimmunol. 2004, 146:203-208.
27. Quandt J., Dorovini-Zis K. The beta chemokines CCL4 and CCL5 enhance adhesion of specific CD4+ T cell subsets to human brain endothelial cells. J. Neuropathol. Exp. Neurol. 2004, 63:350-362.
28. Ransohoff R.M., Hamilton T.A., Tani M., Stoler M.H., Shick H.E., Major J.A., Estes M.L., Thomas D.M., Tuohy V.K. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. Faseb J. 1993, 7:592-600.
29. Rappert A., Bechmann I., Pivneva T., Mahlo J., Biber K., Nolte C., Kovac A.D., Gerard C., Boddeke H.W., Nitsch R., Kettenmann H. CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J. Neurosci. 2004, 24:8500-8509.
30. Rasband W.S. Image J 1997-2007, U.S. National Institutes of Health, Bethesda, Maryland, USA.
31. Rebenko-Moll N.M., Liu L., Cardona A., Ransohoff R.M. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr. Opin. Immunol. 2006, 18:683-689.
32. Sallusto F., Mackay C.R. Chemoattractants and their receptors in homeostasis and inflammation. Curr. Opin. Immunol. 2004, 16:724-731.
33. Sallusto F., Mackay C.R., Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 2000, 18:593-620.
34. Simpson J.E., Newcombe J., Cuzner M.L., Woodroofe M.N. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol. 1998, 84:238-249.
35. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 1999, 103:807-815.
36. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
37. Sui Y., Potula R., Dhillon N., Pinson D., Li S., Nath A., Anderson C., Turchan J., Kolson D., Narayan O., Buch S. Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am. J. Pathol. 2004, 164:1557-1566.
38. Tani M., Ransohoff R.M. Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma?. Brain Pathol. 1994, 4:135-143.
39. Tanuma N., Sakuma H., Sasaki A., Matsumoto Y. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol. 2006, 112:195-204.
40. Tsunoda I., Lane T.E., Blackett J., Fujinami R.S. Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10. Mult. Scler. 2004, 10:26-34.
41. Ubogu E.E., Callahan M.K., Tucky B.H., Ransohoff R.M. CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro. Cell. Immunol. 2006, 243:19-29.
42. Valledor A.F., Ricote M. Nuclear receptor signaling in macrophages. Biochem. Pharmacol. 2004, 67:201-212.
43. van der Laan L.J., Ruuls S.R., Weber K.S., Lodder I.J., Dopp E.A., Dijkstra C.D. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J. Neuroimmunol. 1996, 70:145-152.
44. van Rossum D., Hilbert S., Strassenburg S., Hanisch U.K., Bruck W. Myelin-phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype. Glia 2008, 56:271-283.
45. van Zwam M., Huizinga R., Melief M.J., Wierenga-Wolf A.F., van Meurs M., Voerman J.S., Biber K.P., Boddeke H.W., Hopken U.E., Meisel C., Meisel A., Bechmann I., Hintzen R.Q., t Hart B.A., Amor S., Laman J.D., Boven L.A. Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J. Mol. Med. 2009, 87:273-286.
46. Verschuren L., de Vries-van der Weij, J., Zadelaar S., Kleemann R., Kooistra T. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms. J. Lipid Res. 2009, 50:301-311.
47. Wang X., Ellison J.A., Siren A.L., Lysko P.G., Yue T.L., Barone F.C., Shatzman A., Feuerstein G.Z. Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat. J. Neurochem. 1998, 71:1194-1204.
48. Williams K., Ulvestad E., Waage A., Antel J.P., McLaurin J. Activation of adult human derived microglia by myelin phagocytosis in vitro. J. Neurosci. Res. 1994, 38:433-443.
49. Zeman D., Adam P., Kalistova H., Sobek O., Andel J., Andel M. Cerebrospinal fluid cytologic findings in multiple sclerosis. A comparison between patient subgroups. Acta Cytol. 2001, 45:51-59.